−116A and K BCHE gene variants associated with obesity and hypertriglyceridemia in adolescents from Southern Brazil  by Chaves, Thaís Jannuzzi et al.
Chemico-Biological Interactions 203 (2013) 341–343Contents lists available at SciVerse ScienceDirect
Chemico-Biological Interactions
journal homepage: www.elsevier .com/locate /chembioint116A and K BCHE gene variants associated with obesity and
hypertriglyceridemia in adolescents from Southern Brazil
Thaís Jannuzzi Chaves a, Neiva Leite b, Gerusa Eisfeld Milano b, Gisele Eisfeld Milano b,
Ricardo Lehtonen Rodrigues Souza a, Eleidi Alice Chautard-Freire-Maia a, Lupe Furtado-Alle a,⇑
a Polymorphism and Linkage Laboratory, Department of Genetics, Federal University of Paraná, Brazil
bDepartment of Physical Education, Federal University of Paraná, Brazila r t i c l e i n f o
Article history:




116A and K variants
Hypertriglyceridemia0009 2797-  2012 Elsevier Ireland Ltd.
http://dx.doi.org/10.1016/j.cbi.2012.09.006
⇑ Corresponding author. Address: Rua Francisco
Politécnico/Setor de Ciências Biológicas, Departament
Jardim das Américas, CEP 81531-970 Curitiba, Parana
1554, (041) 9114 5873.
E-mail address: lupealle@gmail.com (L. Furtado-Al
Open access unda b s t r a c t
Butyrylcholinesterase (BChE) has been associated to body mass index (BMI), weight, cholesterol and tri-
glyceride levels. 116A (rs1126680) and K (A539T, 1615A, rs1803274) BCHE gene variants had previously
been associated to BChE activity, weight and BMI variance in adults. The present study examined 116A
and K variants, BChE activity, anthropometric and biochemical variables associated with obesity in ado-
lescents (120 obese and 150 non-obese from Curitiba, Brazil). Both 116A and K variants were found with
signiﬁcantly lower frequencies (p < 0.05) in obese adolescents when compared with non-obese adoles-
cents and with the general population. Mean BChE activity (KU/L) was signiﬁcantly higher in obese ado-
lescents when compared with non-obese adolescents and with the general population. Analyzing only
the obese adolescents, it was found that carriers of the 116A variant showed lower BChE activity and
higher triglyceride levels than homozygotes for the usual allele. Indeed, obese carriers of the 116A var-
iant had triglyceride levels considered high according to reference values for serum triglycerides in Bra-
zilian adolescents. These results show: (1) a protective effect of 116A and K variants on juvenile obesity
risk, suggesting a role for the BCHE gene on juvenile onset obesity different from that observed on adult
onset obesity and (2) an association of the 116A variant with hypertriglyceridemia in obese adolescents
probably because of its effect on lowering BChE activity and consequently diminishing the enzyme capa-
bility of maintaining homeostasis on lipid metabolism during the metabolic stress caused by obesity.
 2012 Elsevier Ireland Ltd. Open access under the Elsevier OA license.1. Introduction
Butyrylcholinesterase (BChE; EC 3.1.1.8) is a serine hydrolase
which is related to lipid metabolism and has been associated to
BMI, waist–hip ratio, waist circumference, weight, cholesterol
and triglyceride levels [1–6].
The most common variant of the coding region of the BCHE gene
(3q26.1-q26.2) is the K variant (SNP: G/A; rs1803274; p.A539T;
1615 nt) located at exon 4, found with a frequency of 18.4% in
Euro-Brazilians [7] and which has been associated with higher
BMI variance (2). The non-codifying exon 1 presents a SNP at
116 nt (SNP: G/A; rs1126680), being the 116A preferentially
found in cis with the K variant [8]. The 116A variant was ﬁrst
identiﬁed with a frequency of 8.0% [8] and was associated with
lower BChE activity (4). Although the K variant was originally asso-
ciated to lower BChE activity, it was shown that this variant aloneH dos Santos, 210 Centro
o de Genética, Sala 43, Bairro
, Brazil. Tel.: +55 (041) 3361
le).
er the Elsevier OA license.is not associated with decreased BChE activity, being the 116A
variant necessary for this decrease [4]. In a previous study of our
research group [4], although we did not ﬁnd differences on fre-
quencies of 116A and K variants of BCHE gene between obese
and non-obese adults, we did ﬁnd that samples with different
BMI distributions present different relationships between BCHE
genotypes and BMI.
Considering linkage disequilibrium between these variants lo-
cated at exons 1 and 4 of the BCHE gene, as well as their known
relation with obesity, this study compared genotypes of these
two sites in relation to BChE activity, anthropometric and bio-
chemical variables associated with obesity in obese and in non-ob-
ese adolescents from Curitiba, Brazil.2. Materials and methods
2.1. Samples
Analyses concerning 116A and K variants of the BCHE gene,
and BChE activity used 120 obese adolescents (mean age = 12.8 y ±
0.15 y; 50 girls and 70 boys) and 150 non-obese adolescents (mean
Table 1
Genotype and allele frequencies of 116A and K variants and comparisons between
obese and non-obese adolescents by v2.
116A variant Na Genotype frequenciesb Allele frequencies
GG (%) GA (%) AA (%) G (%) A (%)
Obese 120 93.3 6.7 0 96.7 ± 1.2 3.3 ± 1.2
Non-obese 144 81.9 18.1 0 91.0 ± 1.7 9.0 ± 1.7
v2(1) (p) 6.59 (0.01) 6.13 (0.01)
K variant Na Genotype frequenciesc Allele frequencies
GG (%) GA (%) AA (%) G (%) A (%)
Obese 114 81.6 17.5 0.9 90.8 ± 1.9 9.2 ± 1.9
Non-obese 150 72.5 23.5 4.0 84.2 ± 2.1 15.8 ± 2.1
v2(1) (p) 4.79 (0.09) 4.45 (0.03)
a The difference on number of individuals is due to lack of ampliﬁcation of
samples.
b GG = homozygotes for 116G allele; AA = homozygotes for 116A allele.
c GG = homozygotes for 1615G (usual) allele; AA = homozygotes for 1615A (K)
allele.
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obese were Euro–Brazilians. Weight was measured to the nearest
0.1 kg and stature was measured to the nearest 0.1 cm. The BMI
was standardized to z-score (BMI z-score) through the conversion
of BMI subtracted the value corresponding to the 50th percentile
of BMI and divided by the population standard deviation, as charts
released by the CDC (Center for Disease Control and Prevention), for
every age and each gender [9]. Adolescents were included on this
obese sample according to the following criteria: BMIP 95th per-
centile and stable weight for at least two months. Individuals sub-
mitted to anorexigenic drugs were excluded from the study. The
anthropometric variables evaluated on obese adolescents were:
weight; height; z-score, waist circumference (WC) and waist/
height ratio (WHR). The study was approved by the Ethics Commit-
tee of the Federal University of Paraná.
2.2. DNA and plasma analysis
Mini Kit DNAAmp (Quiagen) was used for DNA extraction from
plasma of 83 obese individuals. After DNA extraction, samples
were dried out and resuspended in 50 ll of ultrapure water to
achieve 20 ng/ll ﬁnal concentration. For the remaining 37 obese
samples and 150 non-obese samples, DNA was extracted by a salt-
ing out method [10] and diluted to 20 ng/ll ﬁnal concentration.
Genotyping of exon 1 and exon 4 variants (rs1126680 and
rs1803274, respectively) were achieved using TaqMan SNP Geno-
typing Assay (Applied Biosystems). Reactions were performed in
Mastercycler Realplex 2 according to the following steps: (1)
50 C/2 min.; (2) 95 C/10 min.; (3) repeat 50 times 95 C/15 s.
interspersed by 62 C/min.
Plasma BChE activity was measured using propionylthiocholine
as substrate at 25 C [11]. Glucose, triglycerides (TG), total choles-Table 2
Means ± standard error (SE) of anthropometric and biochemical variables in obese adolesc
Variables 116 site
116G/116A 116G/116G
Z-score 3.34 ± 1.31 3.49 ± 1.11
WHR 0.61 ± 0.03 0,61 ± 0,01
Total cholesterol 176.1 ± 11.7 156.4 ± 3,2
LDL cholesterol 94.3 ± 9.8 89,6 ± 2,7
HDL cholesterol 45.9 ± 2.8 43.8 ± 0.8
Tryglycerides 244.0 ± 26.0 110,0 ± 10.7
Glucose 88.6 ± 2.8 89.9 ± 0.9
a KK genotype was excluded from analysis (n = 1).
** p values for t-test.terol (TC) and fractions were measured by automated standard
methods.
2.3. Statistical analysis
Frequency distributions, means ± S.E, variances and t-test
were calculated using Statistica for Windows (StatSoft, Inc.,1996;
http://www.statsoft.com). v2-tests were performed using Clump
[12]. SPSS for Windows (SPSS Inc., 2004) was used for multiple
regression analysis.
3. Results and discussion
Table 1 summarizes the results for allele and genotype frequen-
cies in obese and non obese adolescents and comparisons between
groups. K variant frequencies are signiﬁcantly lower in obese than
in non-obese adolescents (v2 = 4.45; p = 0.03), as well as in obese
adolescents when compared with those found in adult blood do-
nors from Curitiba, PR (7; v2 = 5.47; p = 0.02). Analyses of 116A
allele frequency revealed that it is signiﬁcantly lower in obese than
in non-obese (v2 = 6.13; p = 0.01). The 116A allele frequencies are
also lower in obese adolescents than in a blood donor sample from
Curitiba, PR (7; v2 = 6.77; p = 0.009). Considering that the present
study found lower frequencies for 116A and K variants in obese
adolescents, it may suggest a protective effect of these variants
on juvenile obesity risk, and a role for the BCHE gene on juvenile
onset obesity stronger and different from that observed on adult
onset obesity. An early onset complex disease, such as juvenile
obesity, may have a distinct (stronger) genetic effect than that of
late onset, such as adult onset obesity which may be highly inﬂu-
enced by environmental factors (nutrition and physical activity).
Comparing mean BChE activity between genotypes of the
116A variant site, it was found, as already shown for obese adults
[4], that mean BChE activity in obese adolescents is lower in 116A
carriers than homozygotes for 116G allele (3.9 ± 0.7 e 7.7 ± 0.3,
respectively; t = 2.9, p = 0.02).
As shown in Table 2, the comparisons regarding biochemical and
anthropometric variables between genotypes of obese adolescents
showed only one signiﬁcant difference: mean triglyceride level is
higher in116A carriers than in -116G/-116G homozygotes. Logistic
regression analysis was performed to verify if the variables sex, age,
z-score, WHR, glucose, 116A and K variants are independent risk
factors for increasing triglycerides level on obese adolescents. The
results revealed that only the 116A variant was a signiﬁcant inde-
pendent factor (B ± SE = 22.7 ± 15.191; p = 0.0001). It is also note-
worthy that the mean triglyceride level of obese bearing the –116A
variant is high according to the reference values proposed for this
age group (ideal values 6130 mg/dL, high values >130; [13]. Previ-
ous studies [14–16] had proposed that the role of BChE on lipid
metabolism could be the hydrolysis of choline esters, which are
products of the free fatty acids metabolism and liver lipogenesis.ents classiﬁed according to genotypes of 116 and 1615 sites of BCHE gene.
1615 sitea
p UK UU p**
0.79 29.6 ± 0.8 29.8 ± 0.6 0.89
0.85 0.61 ± 0.01 0.61 ± 0.08 0.96
0.12 165.5 ± 6,8 156.8 ± 3.7 0.29
0.7 95.9 ± 5.4 88.4 ± 3.1 0.27
0.52 44.5 ± 1.8 44.0 ± 0.9 0.84
0.00002 139.6 ± 20,1 117.5 ± 7.4 0.22
0.68 91.0 ± 1.9 89.5 ± 1.0 0.51
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fatty acid or an increase of lipogenesis from carbohydrates, could
lead to two effects: hyperlipidemia and increased BChE activity.
The 116A variant might be associated with hypertriglyceridemia
in obese adolescents because of its effect on lowering BChE activity
and consequently diminishing the enzyme capability of maintain-
ing homeostasis on lipid metabolism during metabolic stress
caused by obesity.
Conﬂict of interest
The author declare that there are no conﬂicts of interest.
Acknowledgements
Grants and scholarships were received from Coordination for
Improvement of Higher Education (CAPES), National Research
Council (CNPq) and Araucaria Foundation. The second author was
supported by a fellowship from CAPES and researcher of CNPq.
References
[1] V.M. Alcântara, L.C. Oliveira, R.R. Réa, H.L.E. Suplicy, E.A. Chautard-Freire-Maia,
Butyrylcholinesterase activity and metabolic syndrome in obese patients, Clin.
Chem. Lab. Med. 43 (2005) 285–288.
[2] R.L.R. Souza, L.R. Mikami, O.B. Maegawa, E.A. Chautard-Freire-Maia, Four new
mutations in the BCHE gene of human butyrylcholinesterase in a Brazilian
blood donor sample, Mol. Genet. Metab. 84 (2005) 349–353.
[3] E.W. Randell, M.S. Mathews, H. Zhang, J.S. Seraj, G. Sun, Relationship between
serum butyrylcholinesterase and the metabolic syndrome, Clin. Biochem. 38
(2005) 799–805.[4] L. Furtado-Alle, F.A. Andrade, K. Nunes, L.R. Mikami, R.L.R. Souza, E.A.
Chautard-Freire-Maia, Association of variants of the 116 site of the
butyrylcholinesterase BCHE gene to enzyme activity and body mass index,
Chem. Biol. Inter. 175 (2008) 115–118.
[5] T. Iwasaki, M. Yoneda, A. Nakajima, Y. Terauchi, Serum butyrylcholinesterase is
strongly associated with adiposity the serum lipid proﬁle and insulin
resistance, Intern. Med. 46 (2007) 1633–1639.
[6] B. Benyamin, R.P. Middelberg, P.A. Lind, A.M. Valle, S. Gordon, D.R. Nyholt, S.E.
Medland, A.K. Henders, A.C. Heath, P.A. Madden, P.M. Visscher, D.T. O’Connor,
G.W. Montgomery, N.G. Martin, J.B. Whitﬁeld, GWAS of butyrylcholinesterase
activity identiﬁes four novel loci, independent effects within BCHE, and
secondary associations with metabolic risk factors, Hum. Mol. Genet. 15 (20)
(2011) 4504–4514.
[7] R.L.R. Souza, R.M.V. Castro, A. Freund, L. Culpi, E.A. Chautard-Freire-Maia,
Frequencies of the butyrylcholinesterase K mutation in Brazilian populations
of European and African origin, Hum. Biol. 70 (1998) 965–970.
[8] C.F. Bartels, A.F.L. Van der Spek, B.N. La Du, Two polymorphisms in the
noncoding regions of the BCHE gene, Nucleic Acids Res. 18 (1990) 6171.
[9] R.J. Kuczmarski, C.L. Ogden, L.M. Grummer-Strawn, K.M. Flegal, S.S. Guo,
R. Wei, et al., CDC growth charts: United States, Adv. Data 314 (2000)
1–27.
[10] D.K. Lahiri, J.R. Nurnberger, A rapid non-enzymatic method for the preparation
of HMW DNA from blood for RFLP studies, Nucleic Acids Res. 19 (1991)
5444.
[11] A.A. Dietz, H.M. Rubinstein, T. Lubrano, L.K. Hodges, Improved method for the
differentiation of cholinesterase variants, Am. J. Genet. 24 (1972) 58–64.
[12] P.C. Sham, D. Curtis, Monte Carlo tests for associations between disease and
alleles at highly polymorphic loci, Ann. Hum. Genet. 59 (2005) 97–105.
[13] Sociedade Brasileira de Cardiologia, I Diretriz de Prevenção da Aterosclerose
na Infância e Adolescência, Arquivos Brasileiros de Cardiologia 85 (2005) 1–36.
[14] J.W. Clitherow, M. Mitchard, N.J. Harper, The possible biological function of
pseudocholinesterase, Nature 199 (1963) 1000–1001.
[15] K.M. Kutty, S.N. Huang, K.T. Kean, Pseudocholinesterase in obesity:
hypercaloric diet induced changes in experimental obese mice, Experientia
37 (1981) 1141–1142.
[16] M.I. Chu, P. Fontaine, K.M. Kutty, D. Murphy, R. Redheendran, Cholinesterase in
serum and low density lipoprotein of hyperlipidemic patients, Clin. Chim. Acta
85 (1978) 55–59.
